Ozempic’s health benefits keep growing, but are the risks worth it?
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
The FDA is about to make weight-loss drugs a lot harder to get
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Hosted on MSN1d
GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares Rise
The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...
The Grand Junction Daily Sentinel1d
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...
Nine top stock picks to prepare your portfolio for 2025
Health care, ride sharing, and the emerging world of YouTube entertainers are among industries leading investors have picked ...
Barron's3d
Novo Nordisk A/S ADR
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
NVO Stock Down as Medicare Selects Semaglutide Drugs for Price Cuts
Novo Nordisk stock falls as Medicare selects its marketed semaglutide medicines catering to T2D and obesity for price ...
NJBIZ5d
Wegovy, Ozempic targeted for Medicare price negotiations (updated)
The U.S. Centers for Medicare and Medicaid Services released its list of drugs covered under Medicare Part D selected for the ...